Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anglo-Celtic Group is a private life sciences investment and technology development organization founded by the prominent biotechnology entrepreneur Sir Christopher Evans. The group operates as a specialist incubator and strategic management firm, focusing on identifying high-potential scientific innovations and building them into successful commercial enterprises. Over its history, Anglo-Celtic has been instrumental in founding and scaling more than 50 companies, including industry leaders such as Vectura, ReNeuron, and BioVex. The firm provides essential seed capital, leadership, and clinical development expertise to transition academic research into market-ready healthcare solutions. By bridging the gap between laboratory discovery and clinical application, Anglo-Celtic Group remains a significant force in the European biotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anglo-Celtic Group.